Home / Generics

Generics

News

Actavis loses Atelvia patents posted 27/03/2015

Teva Pharmaceutical Industries (Teva) has won a legal battle against Actavis after a federal judge invalidated two patents pr...

Ranbaxy fails to reverse FDA decision over Valcyte and Nexium posted 20/03/2015

Indian generics company Ranbaxy has yet again failed in its bid to become the first company in the US to sell generic version...

Drug companies seek to block generic version of ulcerative colitis therapy posted 17/03/2015

The patent holder and manufacturer of Uceris (budesonide), a treatment for ulcerative colitis, have sued generics company Act...

US court invalidates asthma drug patent posted 06/03/2015

The US District Court of New Jersey ruled on 13 February 2015 that the patent protecting AstraZeneca’s inhaled asthma drug Pu...

Actavis receives generic opioid approval and plans name change posted 27/02/2015

US generics maker Actavis announced on 20 February 2015 that it had received final approval from the US Food and Drug Adminis...

 

Research

Generics utilization policies necessary to sustain Medicaid posted 27/03/2015

A review of the history and expansion of generics utilization policies and their critical role in the US Medicaid system in a...

Potential savings of Euros 72 million with more generics use in three therapeutic areas posted 13/03/2015

A nationwide cohort study in Austria reported that substituting branded medications with drugs containing the same active ing...

Poor generics awareness among physicians in Saudi Arabia posted 06/03/2015

A study looking at physicians’ knowledge, opinions and attitudes towards prescribing local generics in Saudi Arabia concludes...

Substitution and adherence to antidiabetic generics in the elderly posted 20/02/2015

When pharmacists switch from brand-name to generic drugs or between the same generics made by different manufacturers, this i...

Generics versus brand-name drugs posted 11/02/2015

Is there a benefit to prescribing brand-name drugs versus prescribing generics? The answer appears to be no, according to evi...

 

General

Health Canada clamps down on GMP compliance posted 20/03/2015

Canada’s federal health department Health Canada has written to its licensed drug and active pharmaceutical ingredients (API)...

FDA cash to develop hard-to-copy generics posted 20/03/2015

The US Food and Drug Administration (FDA) is offering US$850,000 to research teams working on generics development. Funds wil...

Pfizer warns UK doctors not to prescribe generic Lyrica for pain posted 20/03/2015

Pharma giant Pfizer is fighting hard to protect one of its brand-name products, this time its epilepsy treatment Lyrica (preg...

Generics applications under review by EMA – December 2014 posted 20/03/2015

Generic medicines in Europe can be approved either centrally via the European Medicines Agency (EMA) or nationally via the lo...

GPhA comments on generics’ legislation and Trans-Pacific Partnership posted 10/02/2015

Mr Ralph G Neas, President and CEO of the US Generic Pharmaceutical Association (GPhA), has commented on proposed legislation...

Generics News Research General

more

Biosimilars News Research General

more